Pediatric Research Studies

If you are interested in your child participating in pediatric research, please explore the opportunities listed below or talk with your child’s pediatrician.

Protection Against Pneumococcal Disease (GSK)

A pneumococcal vaccine clinical study is now enrolling healthy, full-term (at least 37 weeks gestation) infants between 42 and 90 days old. Click to find out more information about the study.

Learn more about the GSK study.

Protection Against Pneumococcal Disease (Vaxcyte)

Are you the guardian of a healthy child between 42 to 89 days old? You and your child may be eligible for a research study to learn more about a pneumococcal vaccine. Compensation is provided.

Learn more about the Vaxcyte study.

TAP (Tympanocentesis to Assess Pathogens) Study 

Have you ever wondered what causes ear infections? This research study assesses the current types of bacteria and viruses that cause ear infections in young children. It also uses new technology that can help your doctor diagnose an ear infection.

Learn more about the TAP study.

Moderna COVID Vaccine for Infants Under 6-Months (BabyCove)

Are you the parent of a baby under 6 months old? Your baby may be eligible for a research study to evaluate an investigational pediatric vaccine that may protect infants from getting sick if they come in contact with SARS-CoV-2 (also called Coronavirus), which causes COVID-19.

Learn more about the BabyCove study.

Cytomegalovirus (CMV)

Let us be the generation who stands up to cytomegalovirus (CMV), a highly contagious viral infection that can harm an unborn child. Currently, there is no approved vaccine against this devastating virus. The CMVictory Trial is studying an investigational vaccine to protect against CMV infection.

Learn more about the CMV study.